Clinical studies in Mexico 2024, by phase
As of April 2024, most of the clinical trials carried out in Mexico were registered as being on phase 3 (2,354). Meanwhile, another 16 clinical trials were recorded as in early phase 1. However, from the nearly 5,000 clinical studies documented in the country, some were either already completed or no longer active, for different reasons. In 2023, Swiss-based company Roche was expected to be the leader firm among the global top pharmaceutical companies, with some 194 products in its R&D pipeline.
